1. Alginate hydrogels functionalized with β‐cyclodextrin as a local paclitaxel delivery system
- Author
-
Finn Lillelund Aachmann, Berit L. Strand, Line Aanerud Omtvedt, Daria Zaytseva-Zotova, Kåre Andre Kristiansen, and Wenche Iren Strand
- Subjects
Male ,Materials science ,Paclitaxel ,Alginates ,Kinetics ,Biomedical Engineering ,Biomaterials ,chemistry.chemical_compound ,Drug Delivery Systems ,Cell Line, Tumor ,Humans ,Solubility ,Cytotoxicity ,Mechanical Phenomena ,chemistry.chemical_classification ,Cyclodextrin ,beta-Cyclodextrins ,Metals and Alloys ,Hydrogels ,Antineoplastic Agents, Phytogenic ,In vitro ,chemistry ,Drug delivery ,Self-healing hydrogels ,Ceramics and Composites ,Biophysics - Abstract
Modification of drug delivery materials with beta-cyclodextrins (β-CyD) is known to increase solubility of poorly water-soluble drugs, protect drugs from degradation and sustain release. In this study, we developed a hydrogel drug delivery system for local paclitaxel delivery using the natural polysaccharide alginate functionalized with β-CyD-moieties. Paclitaxel was chosen due to its ability to form inclusion complexes with cyclodextrins. The rheological and mechanical properties of the prepared hydro- gels were characterized, as well as in vitro release of the paclitaxel and in vitro activ- ity on PC-3 prostate cancer cells. Introduction of β-CyD-moieties into the hydrogel reduces the mechanical properties of the gels compared to nonmodified gels. How- ever, gelation kinetics were not markedly different. Furthermore, the β-CyD-modified alginate helped to reduce undesired crystallization of the paclitaxel in the gel and facilitated paclitaxel diffusion out of the gel network. Remarkably, the β-CyD grafted alginate showed increased capacity to complex paclitaxel compared to free HPβ- CyD. Release of both paclitaxel and degradation products were measured from the gels and were shown to have cytotoxic effects on the PC-3 cells. The results indicate that functionalized alginate with β-CyDs has potential as a material for drug delivery systems.
- Published
- 2021
- Full Text
- View/download PDF